Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Harris

Showing results (121-130 of 200) with videos related to

Pageof 20
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2026
Antibiotic Clinical Trials: A Review of the Past, Present Challenges, and Potential SolutionsMelissa J Hardy, Patrick N A Harris, Yin Mo, et al.
Heart & Lung : the Journal of Critical Care|August 30, 2022
A pilot randomized controlled trial of securement bundles to reduce peripheral intravenous catheter failureAmanda Corley, Amanda J Ullman, Nicole Marsh, et al.
Open Forum Infectious Diseases|October 23, 2025
Snapshot Genomic Surveillance Reveals Insights into Antimicrobial Resistance and Lineage Diversity of Uropathogens in Older Adults in QueenslandBudi Permana, Caitlin Falconer, Johanna Mayer-Coverdale, et al.
Microorganisms|July 27, 2022
<i>Achromobacter</i> Species: An Emerging Cause of Community-Onset Bloodstream InfectionsBurcu Isler, David L Paterson, Patrick N A Harris, et al.
Internal Medicine Journal|December 6, 2018
Fosfomycin: what was old is new againMinyon L Avent, Benjamin A Rogers, Allen C Cheng, et al.
BMJ Open|June 27, 2023
Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trialBenjamin A Rogers, Robert Fowler, Patrick N A Harris, et al.
Antimicrobial Agents and Chemotherapy|November 10, 2020
Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible <i>In Vitro</i> to Cefiderocol, a Siderophore CephalosporinDelaney Burnard, Gemma Robertson, Andrew Henderson, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 12, 2023
Comparison of Low-Level to High-Level Disinfection in Eliminating Microorganisms From Ultrasound Transducers Used on Skin: A Noninferiority Randomized Controlled TrialNathan Peters, Frances Williamson, Michelle J Bauer, et al.
Microbiology Spectrum|May 16, 2023
Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in QueenslandBudi Permana, Patrick N A Harris, Naomi Runnegar, et al.
BJU International|May 17, 2022
Guideline of guidelines: management of recurrent urinary tract infections in womenMichael Kwok, Stephen McGeorge, Johanna Mayer-Coverdale, et al.
Pageof 20

Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2026
Antibiotic Clinical Trials: A Review of the Past, Present Challenges, and Potential SolutionsMelissa J Hardy, Patrick N A Harris, Yin Mo, et al.
Heart & Lung : the Journal of Critical Care|August 30, 2022
A pilot randomized controlled trial of securement bundles to reduce peripheral intravenous catheter failureAmanda Corley, Amanda J Ullman, Nicole Marsh, et al.
Open Forum Infectious Diseases|October 23, 2025
Snapshot Genomic Surveillance Reveals Insights into Antimicrobial Resistance and Lineage Diversity of Uropathogens in Older Adults in QueenslandBudi Permana, Caitlin Falconer, Johanna Mayer-Coverdale, et al.
Microorganisms|July 27, 2022
<i>Achromobacter</i> Species: An Emerging Cause of Community-Onset Bloodstream InfectionsBurcu Isler, David L Paterson, Patrick N A Harris, et al.
Internal Medicine Journal|December 6, 2018
Fosfomycin: what was old is new againMinyon L Avent, Benjamin A Rogers, Allen C Cheng, et al.
BMJ Open|June 27, 2023
Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trialBenjamin A Rogers, Robert Fowler, Patrick N A Harris, et al.
Antimicrobial Agents and Chemotherapy|November 10, 2020
Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible <i>In Vitro</i> to Cefiderocol, a Siderophore CephalosporinDelaney Burnard, Gemma Robertson, Andrew Henderson, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 12, 2023
Comparison of Low-Level to High-Level Disinfection in Eliminating Microorganisms From Ultrasound Transducers Used on Skin: A Noninferiority Randomized Controlled TrialNathan Peters, Frances Williamson, Michelle J Bauer, et al.
Microbiology Spectrum|May 16, 2023
Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in QueenslandBudi Permana, Patrick N A Harris, Naomi Runnegar, et al.
BJU International|May 17, 2022
Guideline of guidelines: management of recurrent urinary tract infections in womenMichael Kwok, Stephen McGeorge, Johanna Mayer-Coverdale, et al.
Pageof 20